We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Michael has over 20 years of corporate finance and accounting experience, 15 of which have been in publicly-traded companies in the life science industry. Most recently, Michael was the Chief Financial Officer of Ocera Therapeutics, which was acquired by Mallinckrodt Pharmaceuticals in 2017. Prior to that, Michael held finance positions of increasing responsibility at Maxygen, NeurogesX, Lipid Sciences and ADAC Labs. Michael received his B.S.C. in Finance from Santa Clara University and his M.B.A. from California State University, Hayward.
This speaker's sessions: